NHE7 Antikörper
Kurzübersicht für NHE7 Antikörper (ABIN635882)
Target
Alle NHE7 (SLC9A7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Affinity purified
-
Immunogen
- SLC9 A7 antibody was raised using a synthetic peptide corresponding to a region with amino acids LGWGLRVAAAASASSSGAAAEDSSAMEELATEKEAEESHRQDSVSLLTFI
-
-
-
-
Applikationshinweise
-
WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
SLC9A7 Blocking Peptide, (ABIN940387), is also available for use as a blocking control in assays to test for specificity of this SLC9A7 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SLC0 7 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NHE7 (SLC9A7) (Sodium Hydrogen Exchanger 7 (SLC9A7))
-
Andere Bezeichnung
- SLC9A7
-
Hintergrund
- Organelles of the secretory and endocytic pathways are distinguished by their luminal acidity, which is generated by the activity of an electrogenic vacuolar-type hydrogen ATPase. Progressive acidification of vesicles in the endocytic pathway is essential for the redistribution and degradation of internalized membrane proteins, such as ligand receptor complexes and fluid-phase solutes. It may play an important role in maintaining cation homeostasis and function of the trans-Golgi network.
-
Molekulargewicht
- 80 kDa (MW of target protein)
Target
-